Effect of probiotic bacteria on the intestinal microbiota in irritable bowel syndrome

Journal of Gastroenterology and Hepatology (Australia)

Volumn 28, Issue 10, 2013, Pages 1624-1631

  Ng, Siew Chien ^a   Lam, Emma F C ^a   Lam, Tommy T Y ^c   Chan, Yawen ^a   Law, Wendy ^a   Tse, Pete C H ^a   Kamm, Michael A ^b,d   Sung, Joseph J Y ^a   Chan, Francis K L ^a   Wu, Justin C Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

IBS; Intestinal microbiota; Probiotics; Pyrosequencing

Indexed keywords

PROBIOTIC AGENT; RNA 16S; UNCLASSIFIED DRUG; VSL#3; VSL3;

ACTINOBACTERIA; ACTINOMYCES; ADULT; ARTICLE; ATOPOBIUM; BACTERIUM; BACTEROIDES; BACTEROIDETES; BREVUNDIMONAS; BUTYRICICOCCUS; CAMPYLOBACTER; CLINICAL ARTICLE; COLONOSCOPY; CONSTIPATION; CONTROLLED STUDY; COPROCOCCUS; CORYNEBACTERIUM; CYANOBACTERIUM; DEVOSIA; DIARRHEA; DISEASE DURATION; DOREA; EPSILONPROTEOBACTERIA; FAECALIBACTERIUM; FEMALE; FIRMICUTES; FLAVOBACTERIA; FUSOBACTERIA; GENE AMPLIFICATION; GENUS; GRANULICATELLA; HUMAN; INTESTINE FLORA; IRRITABLE COLON; LACHNOSPIRACEAE; MALE; METHYLOBACTERIUM; MICROBACTERIUM; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; NEISSERIA; OPEN STUDY; OXALOBACTERACEAE; PARABACTEROIDES; PHENOTYPE; PHYLUM; PILOT STUDY; PRIORITY JOURNAL; PROPIONIBACTERIUM; PROTEOBACTERIA; PYROSEQUENCING; RECTUM BIOPSY; ROSEBURIA; RUMINOCOCCACEAE; SCHLEGELELLA; SELENOMONAS; SMOKING; STREPTOCOCCUS; SYMPTOM ASSESSMENT; SYNEGITESTES; THERAPY EFFECT; VEILLONELLA; XANTHOMONADACEAE;

IBS; INTESTINAL MICROBIOTA; PROBIOTICS; PYROSEQUENCING;

ADMINISTRATION, ORAL; ADULT; BACTERIA; FEMALE; GENES, BACTERIAL; HUMANS; INTESTINAL MUCOSA; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PHYLOGENY; POLYMERASE CHAIN REACTION; PROBIOTICS; RNA, RIBOSOMAL, 16S;

EID: 84897653618     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12306     Document Type: Article

References (37)

1. Wilson S, Roberts L, Roalfe A etal. Prevalence of irritable bowel syndrome: a community survey. Br. J. Gen. Pract. 2004; 54: 495-502.
2. Talley NJ, Spiller R. Irritable bowel syndrome: a little understood organic bowel disease? Lancet 2002; 360: 555-564.
3. Karantanos T, Markoutsaki T, Gazouli M etal. Current insights in to the pathophysiology of Irritable Bowel Syndrome. Gut Pathog. 2010; 2: 3.
4. Gill SR, Pop M, Deboy RT etal. Metagenomic analysis of the human distal gut microbiome. Science 2006; 312: 1355-1359.
5. Neal KR, Hebden J, Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. BMJ 1997; 314: 779-782.
6. Spiller R, Campbell E. Post-infectious irritable bowel syndrome. Curr. Opin. Gastroenterol. 2006; 22: 13-17.
7. Gwee KA, Graham JC, McKendrick MW etal. Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet 1996; 347: 150-153.
8. Kassinen A, Krogius-Kurikka L, Makivuokko H etal. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007; 133: 24-33.
9. Parkes GC, Sanderson JD, Whelan K. Treating irritable bowel syndrome with probiotics: the evidence. Proc. Nutr. Soc. 2010; 69: 187-194.
10. Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am. J. Gastroenterol. 2000; 95: 3503-3506.
11. Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study. Am. J. Gastroenterol. 2003; 98: 412-419.
12. Carroll IM, Ringel-Kulka T, Keku TO etal. Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. Am. J. Physiol. Gastrointest. Liver Physiol. 2011; 301: G799-G807.
13. Longstreth GF, Thompson WG, Chey WD etal. Functional bowel disorders. Gastroenterology 2006; 130: 1480-1491.
14. Liu Z, Lozupone C, Hamady M etal. Short pyrosequencing reads suffice for accurate microbial community analysis. Nucleic Acids Res. 2007; 35: e120.
15. Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 2010; 26: 2460-2461.
16. Cole JR, Wang Q, Cardenas E etal. The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res. 2009; 37 (Database issue): D141-D145.
17. Wang Q, Garrity GM, Tiedje JM etal. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 2007; 73: 5261-5267.
18. Oksanen J, Blachet FG, Kindt R etal. Community Ecology Package. R package. 2011. Cited 1 July 2012. Available from URL: http://CRAN.R-project.org/package=vegan
19. Xia J, Wishart DS. Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst. Nat. Protoc. 2011; 6: 743-760.
20. Hamady M, Lozupone C, Knight R. Fast UniFrac: facilitating high-throughput phylogenetic analyses of microbial communities including analysis of pyrosequencing and PhyloChip data. ISME J. 2010; 4: 17-27.
21. Haas BJ, Gevers D, Earl AM etal. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res. 2011; 21: 494-504.
22. Arumugam M, Raes J, Pelletier E etal. Enterotypes of the human gut microbiome. Nature 2011; 473: 174-180.
23. Martens EC, Koropatkin NM, Smith TJ etal. Complex glycan catabolism by the human gut microbiota: the Bacteroidetes Sus-like paradigm. J. Biol. Chem. 2009; 284: 24673-24677.
24. Louis P, Flint HJ. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol. Lett. 2009; 294: 1-8.
25. Willing BP, Dicksved J, Halfvarson J etal. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 2010; 139: 1844-1854.
26. Malinen E, Rinttila T, Kajander K etal. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am. J. Gastroenterol. 2005; 100: 373-382.
27. Maukonen J, Satokari R, Matto J etal. Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria 1. J. Med. Microbiol. 2006; 55 (Pt 5): 625-633.
28. Krogius-Kurikka L, Lyra A, Malinen E etal. Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol. 2009; 9: 95.
29. Rajilić-Stojanović M, Biagi E, Heilig HG etal. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 2011; 141: 1792-1801.
30. Saulnier DM, Riehle K, Mistretta TA etal. Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology 2011; 141: 1782-1791.
31. Ouwehand AC, Salminen S, Arvola T etal. Microbiota composition of the intestinal mucosa: association with fecal microbiota? Microbiol. Immunol. 2004; 48: 497-500.
32. Durban A, Abellan JJ, Jimenez-Hernandez N etal. Assessing gut microbial diversity from feces and rectal mucosa. Microb. Ecol. 2011; 61: 123-133.
33. Lepage P, Seksik P, Sutren M etal. Biodiversity of the mucosa-associated microbiota is stable along the distal digestive tract in healthy individuals and patients with IBD. Inflamm. Bowel Dis. 2005; 11: 473-480.
34. Kim HJ, Vazquez Roque MI, Camilleri M etal. A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol. Motil. 2005; 17: 687-696.
35. Kim HJ, Camilleri M, McKinzie S etal. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment. Pharmacol. Ther. 2003; 17: 895-904.
36. Moayyedi P, Ford AC, Talley NJ etal. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 2010; 59: 325-332.
37. Harrell L, Wang Y, Antonopoulos D etal. Standard colonic lavage alters the natural state of mucosal-associated microbiota in the human colon. PLoS ONE 2012; 7: e32545.